Skip to content

Zeiss Meditec presents figures for the fiscal year

The Executive Board of the medical technology group Carl Zeiss Meditec reported on the 2022/23 financial year in Jena on Tuesday. In the first nine months, the company generated revenue of around 1.5 billion euros - an increase of 13.3 percent compared to the same period last year. Production...

The Carl Zeiss Meditec AG building. Photo.aussiedlerbote.de
The Carl Zeiss Meditec AG building. Photo.aussiedlerbote.de

Medical technology - Zeiss Meditec presents figures for the fiscal year

The Executive Board of the medical technology group Carl Zeiss Meditec reported on the 2022/23 financial year in Jena on Tuesday. In the first nine months, the company generated revenue of around 1.5 billion euros - an increase of 13.3 percent compared to the same period last year. Production capacities are to be expanded in response to a good order situation. The company, which is listed on the Frankfurt Stock Exchange's MDax, employs around 4600 people in Germany and abroad. Zeiss Meditec specializes in lasers, lenses and surgical microscopes for the treatment of eye diseases.

Read also:

  1. The city of Jena, known for its rich optics history, is where the headquarters of Zeiss Meditec, a significant player in the medical technology sector, is located.
  2. Despite being based in Thuringia, a region known for its Industrial Revolution contributions, Zeiss Meditec's shares are traded on the Frankfurt Stock Exchange's MDAX, a segment focusing on medium-sized companies.
  3. During the recent financial year discussions, the company hinted at potentially increasing its production capacities in response to the positive orders, expected to benefit several of its plants in both Germany and international locations.

Source: www.stern.de

Comments

Latest

Grave accusations levied against JVA staff members in Bavaria

Grave accusations levied against JVA staff members in Bavaria

Grave accusations levied against JVA staff members in Bavaria The Augsburg District Attorney's Office is currently investigating several staff members of the Augsburg-Gablingen prison (JVA) on allegations of severe prisoner mistreatment. The focus of the investigation is on claims of bodily harm in the workplace. It's

Members Public